ACETO Corp's subsidiary to launch Ultramicrosize Griseofluvin tablets

By Admin
ACETO Corporation's finished dosage form generics subsidiary namely Rising Pharmaceuticals Inc will be launching the first generic version of the 1...

ACETO Corporation's  finished dosage form generics subsidiary namely Rising Pharmaceuticals Inc will be launching the first generic version of the 125mg and 250mg strengths of Ultramicrosize Griseofluvin tablets USP.

These tablets are the FDA approved generic version of PEDiNOL Pharmacal Inc’s Gris-PEG®. According to the IMS Health Data, the U.S. market sales for ultramicrosize Griseofluvin tablets, that is antifungal antibiotic that fights infections caused by fungus, was approximately $16.7 million for 12 months ended June 30, 2012.

ACETO Corporation is a global leader in the marketing, sale and distribution of products for human health, pharmaceutical ingredients and performance chemicals.

With business operations in nine countries, ACETO distributes more than 1,100 chemical compounds used as finished products or raw materials in the nutraceutical, pharmaceutical, coatings, agricultural, and industrial chemical industries. Its global operations includes a staff of 26 in China and 12 in India, are distinctive in the industry and enables its worldwide sourcing and regulatory capabilities. 

Rising Pharmaceuticals is engaged in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products. Its products are manufactured in state-of-the-art GMP facilities using quality assurance techniques that meet regulatory standards. 

The company shares its own distribution channel analysis and marketing innovation and also dedicates itself to supporting its partners’ existing marketing programs.

Share
Share

Featured Articles

McKinsey: Consumers Demand Data-driven Wellness Products

New McKinsey Future of Wellness survey shows that consumers demand data-driven wellness solutions to improve health, sleep, nutrition, fitness & longevity

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

Medical Devices & Pharma

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI